0001209191-18-036863.txt : 20180611 0001209191-18-036863.hdr.sgml : 20180611 20180611115929 ACCESSION NUMBER: 0001209191-18-036863 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180607 FILED AS OF DATE: 20180611 DATE AS OF CHANGE: 20180611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUDNICK SETH CENTRAL INDEX KEY: 0001184420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 18891403 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 STREET 2: C/O ARALEZ PHARMACEUTICALS CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 79 T.W. ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: P. O. BOX # 110341 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-07 0 0001560241 G1 Therapeutics, Inc. GTHX 0001184420 RUDNICK SETH C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR. 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 1 0 0 0 Stock Option (right to buy) 38.39 2018-06-07 4 A 0 10000 0.00 A 2028-06-07 Common Stock 10000 10000 D The shares underlying this option will vest in their entirety twelve months after June 7, 2018, subject to the Reporting Person's continued service as a director. /s/ Megan Gates, attorney-in-fact 2018-06-11